Search Results - "Poewe, W."

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.

Authors: Rascol O Brooks DJ Melamed E et al.

Source: Lancet. 3/12/2005, Vol. 365 Issue 9463, p947-954. 8p.

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO,Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.

Authors: Rascol, O Brooks, D.J. Melamed, E. et al.

Source: Lancet. 3/12/2005, Vol. 365 Issue 9463, p947-954. 8p. 1 Diagram, 4 Charts, 3 Graphs.

Subjects: Parkinson's disease, Dopa, Phenylalanine, Catecholamines, Brain diseases, Monoamine oxidase, Amine oxidase

Treatment interventions for Parkinson's disease: an evidence based assessment.

Authors: Rascol O Goetz C Koller W et al.

Source: Lancet. 5/4/2002, Vol. 359 Issue 9317, p1589-1598. 10p.

Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study).

Authors: Poewe, W. H Deuschl, G Gordin, A et al.

Source: Acta Neurologica Scandinavica. Apr2002, Vol. 105 Issue 4, p245-255. 11p. 1 Diagram, 5 Charts, 5 Graphs.

Subjects: Methyltransferases, Entacapone, Parkinson's disease, Chemical inhibitors

Geographic Terms: Europe

Functional connectivity and topology in patients with restless legs syndrome: a case–control resting‐state functional magnetic resonance imaging study.

Authors: Tuovinen, N. Stefani, A. Mitterling, T. et al.

Source: European Journal of Neurology. Feb2021, Vol. 28 Issue 2, p448-458. 11p.

Subjects: Functional magnetic resonance imaging, Restless legs syndrome, Functional connectivity, Independent component analysis, Diagnostic imaging

Distal myasthenia gravis – frequency and clinical course in a large prospective series.

Authors: Werner, P. Kiechl, S. Löscher, W. et al.

Source: Acta Neurologica Scandinavica. Sep2003, Vol. 108 Issue 3, p209-211. 3p.

Subjects: Myasthenia gravis, Neuromuscular diseases, Neurological disorders, Muscle diseases

Juvenile asymmetric segmental spinal muscular atrophy (Hirayama's disease) Three cases without evidence of “flexion myelopathy”.

Authors: Willeit, J. Kiechl, S. Kiechl-Kohlendorfer, U. et al.

Source: Acta Neurologica Scandinavica. Nov2001, Vol. 104 Issue 5, p320-322. 3p. 4 Black and White Photographs.

Subjects: Spinal muscular atrophy, Cervical vertebrae diseases

Long‐term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open‐label extensions.

Authors: Ferreira, J. J. Lees, A. Rocha, J.‐F. et al.

Source: European Journal of Neurology. Jul2019, Vol. 26 Issue 7, p953-960. 8p. 1 Diagram, 2 Charts, 2 Graphs.

Subjects: Parkinson's disease, Data analysis, Clinical trials

Characterization of the pattern of daily motor fluctuations in Parkinson's disease patients based on home diaries.

Authors: Hauser, R.A. Poewe, W. Ferreira, J.J. et al.

Source: Parkinsonism & Related Disorders. May2024, Vol. 122, pN.PAG-N.PAG. 1p.

Effect of opicapone and entacapone on early morning-OFF pattern in Parkinson's disease patients with motor fluctuations.

Authors: Videnovic, A. Poewe, W. Lees, A. et al.

Source: Parkinsonism & Related Disorders. May2024, Vol. 122, pN.PAG-N.PAG. 1p.

Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson's disease: Three-year data from the open-label BeyoND study.

Authors: Stocchi, F. Poewe, W. Ellenbogen, A. et al.

Source: Parkinsonism & Related Disorders. May2024, Vol. 122, pN.PAG-N.PAG. 1p.

Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease.

Authors: Hauser, R. A. Schapira, A. H. V. Barone, P. et al.

Source: European Journal of Neurology. May2014, Vol. 21 Issue 5, p736-743. 8p.

Subjects: Pramipexole, Drowsiness, Edema, Backache, Dyskinesias

Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease.

Authors: Schapira, A. H. V. Barone, P. Hauser, R. A. et al.

Source: European Journal of Neurology. Jan2013, Vol. 20 Issue 1, p180-187. 8p. 1 Diagram, 4 Charts, 1 Graph.

Subjects: Parkinson's disease treatment, Pramipexole, Drug efficacy, Dopa, Placebos

The PRIPS study: screening battery for subjects at risk for Parkinson's disease.

Authors: Berg, D. Godau, J. Seppi, K. et al.

Source: European Journal of Neurology. Jan2013, Vol. 20 Issue 1, p102-108. 7p. 1 Diagram, 4 Charts.

Subjects: Parkinson's disease & genetics, Genetic testing, Substantia nigra, Family history (Medicine), Genetic disorder diagnosis

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease.

Authors: Schapira, A. H. V. Barone, P. Hauser, R. A. et al.

Source: European Journal of Neurology. Jan2013, Vol. 20 Issue 1, p50-56. 7p. 2 Diagrams, 3 Charts, 1 Graph.

Subjects: Drug dosage, Surveys, Parkinson's disease treatment, Blind experiment, Pramipexole, Placebos, Chronic diseases

EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease.

Authors: Berardelli, A. Wenning, G. K. Antonini, A. et al.

Source: European Journal of Neurology. Jan2013, Vol. 20 Issue 1, p16-34. 19p. 9 Black and White Photographs, 4 Charts.

Subjects: Parkinson's disease diagnosis, Transcranial Doppler ultrasonography, Brain imaging, Neurological disorders, Movement disorders, Etiology of diseases

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

Authors: Ferreira, J. J. Katzenschlager, R. Bloem, B. R. et al.

Source: European Journal of Neurology. Jan2013, Vol. 20 Issue 1, p5-15. 11p. 6 Charts.

Subjects: Parkinson's disease treatment, Drug therapy, Neurology periodicals, Periodical publishing, MEDLINE

Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease.

Authors: Scherfler C Seppi K Mair KJ et al.

Source: Brain: A Journal of Neurology; Nov2012, Vol. 135 Issue 11, p3348-3354, 7p

Long-term safety of continuous levodopa/carbidopa infusion with ND0612: results from the ongoing BeyoND study.

Authors: Poewe, W. Stocchi, F. Sopromadze, S. et al.

Source: Parkinsonism & Related Disorders. 2023 Supplement, Vol. 113, pN.PAG-N.PAG. 1p.

Perspectives on recent advances in the understanding and treatment of Parkinson’s disease.

Authors: Schapira, A. H. Agid, Y. Barone, P. et al.

Source: European Journal of Neurology. Oct2009, Vol. 16 Issue 10, p1090-1099. 10p. 3 Charts, 1 Graph.

Subjects: Parkinson's disease treatment, Mental depression, Dopamine agonists, Mitochondria, Dopa